VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
NERVMinerva Neurosciences, Inc.$4.51$32M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksNERVEarnings History

NERV logoMinerva Neurosciences, Inc. (NERV) Earnings History

Net Loss

14 years of earnings data (2012–2025) · Currently unprofitable on a TTM basis

TTM Net Income
-$415M
● Net Loss
TTM EPS (Diluted)
$-9.46
Per share, diluted
YoY EPS Growth
-18347.4%
Declining
Net Margin
N/A
After-tax profitability
EPS Growth Rate (CAGR)
1YN/A
3YN/A
5YN/A
10YN/A
Operating MarginN/A
Gross MarginN/A
Return on EquityN/A
Return on Assets-434.3%
Record Annual Net Income$2MFY2020
Record Quarterly EPS$5.84Q2 2020
Consecutive Profitable Years0years
Q1 2026
Net Income-$125M
EPS (Diluted)$-2.86
YoY Growth-18347.4%Declining
QoQ Growth+55.8%Excellent

Loading earnings history...

Minerva Neurosciences, Inc. (NERV) Earnings Overview

As of June 13, 2026, Minerva Neurosciences, Inc. (NERV) reported trailing twelve-month net income of -$415M, reflecting -18347.4% year-over-year growth. The company earned $-9.46 per diluted share over the past four quarters.

Looking at the long-term picture, NERV's historical earnings data spans multiple years. The company achieved its highest annual net income of $2M in fiscal 2020.

Minerva Neurosciences, Inc. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →

Compared to peers including ACAD ($376M net income, 36.5% margin), INVA ($504M net income, 63.8% margin), AXSM (-$188M net income, -28.7% margin), NERV has comparable earnings metrics. Compare NERV vs ACAD →

NERV Earnings vs Peers

Earnings metrics vs comparable public companies

CompanyTTM Net IncomeTTM EPSNet MarginROEYoY GrowthCompare
NERV logoNERVCurrent
-$415M$-9.46---18347.4%—
ACAD logoACAD
$376M$2.1836.5%39.9%+68.4%
INVA logoINVA
$504M$5.9463.8%29.1%+816.7%
AXSM logoAXSM
-$188M$-3.68-28.7%-252.1%+38.6%
ALTO logoALTO
$29M$0.381.5%5.7%+119.5%
NRXP logoNRXP
-$25M$-0.76-2336.5%-+43.9%
Best in group
Lowest in group

NERV Historical Earnings Data (2012–2025)

14 years
Fiscal Year Net Income YoY % Operating Income EPS (Diluted) Net Margin Op. Margin
2025-$293M-20492.7%-$15M$-34.67--
2024$1M+104.8%-$22M$0.19--
2023-$30M+6.6%-$23M$-4.61--
2022-$32M+35.7%-$25M$-6.01--
2021-$50M-2671.1%-$45M$-9.35--
2020$2M+102.7%$2M$0.384.7%4.5%
2019-$72M-43.9%-$76M$-14.80--
2018-$50M-59.2%-$52M$-10.35--
2017-$32M-1.5%-$41M$-6.65--
2016-$31M-14.6%-$30M$-7.88--
2015-$27M+52.4%-$26M$-9.25--
2014-$57M-1644.4%-$55M$-35.77--
2013-$3M-106.2%-$3M$-1.43--
2012-$2M--$2M$-0.69--

Download Data

Export NERV earnings history in CSV or JSON format

Free sign-in required to download data

What if you invested $1,000 in NERV back in 2012?

Total return with dividends reinvested · 14+ years of data

Calculate Returns

How much would $100/month in NERV be worth today?

Dollar cost averaging vs lump sum · see how regular investing compounds over time

Run the Numbers

Is NERV Undervalued Right Now?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

NERV vs LLY — which is the better buy?

Side-by-side revenue, margins, P/E and 10-year returns vs Eli Lilly and Company.

Compare Now

NERV — Frequently Asked Questions

Quick answers to the most common questions about buying NERV stock.

What is NERV earnings per share (EPS)?

NERV trailing twelve-month (TTM) diluted EPS is $-9.46, reflecting -18347.4% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2012 to 2025 is available in the table on this page.

What is Minerva Neurosciences, Inc.'s net income?

Minerva Neurosciences, Inc. (NERV) trailing twelve-month net income is $-415M as of 2025. Earnings declined -18347.4% year-over-year.

Is NERV profitable?

NERV is not currently profitable on a TTM basis, reporting a net loss of $-415M. Net margin is N/A. Investors should monitor for a return to profitability.

What is NERV's earnings growth rate?

NERV compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2012 to 2025.

What are NERV's profit margins?

Minerva Neurosciences, Inc. net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is N/A.

Is NERV growing earnings?

NERV earnings are declining — EPS fell -18347.4% year-over-year. TTM net income dropped to $-415M. This contrasts with the 5-year CAGR of N/A.

What was NERV's best earnings year?

Minerva Neurosciences, Inc.'s highest annual net income on record is $2M, achieved in fiscal year 2020. Earnings history on this page spans 2012 to 2025 and includes all annual and quarterly figures.

What were NERV's earnings last quarter?

NERV's most recent reported quarter was Q1 2026. Net income was $-125M with diluted EPS of $-2.86. For a full breakdown of all quarters, see the quarterly earnings table on this page.

NERV Earnings Over Time (2012–2025)

Net income & EPS — annual and quarterly view